Women's Health Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly


We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Breast Cancer

Gemcitabine used as salvage chemotherapy in pretreated metastatic breast cancer

According to a study from South Korea, "We evaluated the efficacy and tolerability of gemcitabine monotherapy in heavily pretreated, breast cancer patients as salvage chemotherapy."

"A weekly infusion of gemcitabine at 850 mg/m² for 30 min, for 3 of every 4 weeks, was introduced in advanced breast cancer patients who had failed previous doxorubicin and taxane based chemotherapy. There was no dose modification, and the treatment was delayed until the leukopenia was recovered with G-CSF support," explained S.U. Rha and colleagues,...

• View Other Issues of Women's Health Weekly
  
• View Other NewsRx Publications